Viewing StudyNCT05664139



Ignite Creation Date: 2024-05-06 @ 6:27 PM
Last Modification Date: 2024-10-26 @ 2:48 PM
Study NCT ID: NCT05664139
Status: NOT_YET_RECRUITING
Last Update Posted: 2023-02-08
First Post: 2022-12-08

Brief Title: Recombinant Human Adenovirus Type 5 Injection Combined With PD-1 Monoclonal Antibody and Nab-paclitaxel in the Treatment of Patients With Liver Metastases From Malignant Melanoma
Sponsor: Fujian Cancer Hospital
Organization: Fujian Cancer Hospital

Organization Data

Organization: Fujian Cancer Hospital
Class: OTHER_GOV
Study ID: FJCH-HR-001
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Fujian Cancer Hospital
Lead Sponsor Class: OTHER_GOV
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
SunWay Biotech Co LTD INDUSTRY
Jiangsu Hengrui Pharmaceutical Co Ltd INDUSTRY